Virusight receives GLOMO Award nomination for COVID-19 innovation

Virusight Diagnostic, a specialist in artificial intelligence software for pathogens diagnosis using spectral technology, has been nominated for ‘Best Innovation for COVID-19 Pandemic Response & Recovery’ at this year’s Global Mobile Awards (GLOMO Awards) by the GSMA, organiser of MWC Barcelona.

Virusight was established as a joint venture of ARC at Sheba Medical Center in Israel and Newsight Imaging, creators of innovative CMOS technology including its next-generation 3D sensors for metaverse, which will also be on display at the upcoming MWC Barcelona event.

Virusight’s innovative solution to COVID-19 enables almost real time detection and analysis of pathogens to help prevent the spread of infection. The device - SpectraLIT - is an easily portable, low-cost point-of-care testing solution that uses spectrophotometry to generate high resolution spectral signatures of a sample’s contents. These signatures are interpreted using artificial intelligence within 20 seconds as either positive or negative for SARS-Cov-2, the virus that causes COVID-19.

Gary Cohen, CEO of Virusight, said: “Clinical trials of a non-invasive oral sampling kit are well underway with preliminary results indicating high correlation with PCR. We provide the same convenience and portability of rapid antigen tests but with a higher accuracy and the immediate identification of those who are infectious, which makes Virusight’s solution ideal for workplaces, airports, cruise lines and educational institutions.

“We have expressions of interest from several European ministries of Health and Education to implement our solution into schools and are working with one of the world’s largest cruise lines to test staff regularly and ensure the safety of their passengers. It is very exciting to have our technology recognised by GLOMO as we truly hope to make a difference and help relieve the effects of the pandemic.”

Virusight is now advancing its sample collection techniques through the availability of a saliva swab testing approach. With trials indicating high accuracy equivalent with PCR standards, this technique is a less intrusive alternative to traditional testing methods.

The GLOMO Awards ceremony will be held in MWC Barcelona at 12 – 1 pm (CET) Wednesday, March 2nd, 2022.